At Biogenesis our mission is to set to pivot towards a new paradigm of drug development, which is that of decentralization, automation, and unprecedented speed. These three pillars will create an environment where scientists are liberated from time-consuming logistics to harness their creative potential fully. The moonshot is to be the supporting infrastructure for the cure for cancer, for which we will need a personalized approach. That will only be able if scientists would be able to fully focus on the science, not the multifaceted complexities often slow research progression.

The future of drug development as we see ts is that where the execution of groundbreaking ideas and clinical trials isn't mired in paperwork or logistical hurdles, but instead, is propelled by sophisticated, autonomous systems. This would allow for only one person, to run trials end-to-end. The future of drug development rests on this revolutionary Drug Research as a Service (DRaaS) model, powered by artificial intelligence, novel systems, and largely free from human intervention.